NEW YORK, March 26, 2020 – JDRF, the global leader in type 1 diabetes (T1D) research, has provided resources and guidance to the T1D community on how to manage their T1D during the coronavirus (COVID-19) pandemic. Key medical experts have said that individuals with well-managed T1D are not at increased risk of contracting COVID-19, but COVID-19 and similar viral illnesses, such as the flu, can pose a serious health risk for people with T1D.

JDRF has compiled detailed to help members of the T1D community make informed decisions regarding their health and well-being. If members of the T1D community do feel under the weather, JDRF encourages increased monitoring of blood glucose and ketones, and stocking up on items that will help keep up carbohydrate intake in a healthy way. It is more important than ever to continue a normal schedule of medications and to be aware of the effects of over-the-counter medications on blood glucose levels. If you still have concerns or questions, we strongly urge you to contact your physician or healthcare provider.

In the event of economic hardship, JDRF also has information available to help people manage health insurance and navigate the healthcare issues.

About JDRF

JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2.2 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact and uniting on a national stage to pool resources, passion and energy. We collaborate with academic institutions, policymakers and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our five international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter: @JDRF.